Medicare Part B Drug "Least Costly Alternative" Policy Rescinded By CMS

The Centers for Medicare and Medicaid Services has officially notified its contractors to stop using an option to limit payments for Medicare Part B drugs to the "least costly alternative" in a therapeutic class